Profound Medical Corp. (NASDAQ: PROF) is 32.00% higher on its value in year-to-date trading and has touched a low of $6.53 and a high of $27.35 in the current 52-week trading range. The PROF stock was last observed hovering at around $26.12 in the last trading session, with the day’s gains setting it 1.02% off its average median price target of $28.41 for the next 12 months. It is also 17.76% off the consensus price target high of $33.00 offered by 8 analysts, but current levels are -64.48% lower than the price target low of $16.50 for the same period.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
Currently trading at $27.14, the stock is 9.31% and 26.66% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.15 million and changing 3.91% at the moment leaves the stock 61.76% off its SMA200. PROF registered 62.61% gain for a year compared to 6-month gain of 71.99%. The firm has a 50-day simple moving average (SMA 50) of $22.99 and a 200-day simple moving average (SMA200) of $18.23.
The stock witnessed a 30.67% loss in the last 1 month and extending the period to 3 months gives it a 54.56%, and is 1.69% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.33% over the week and 5.00% over the month.
Distance from 52-week low is 315.62% and -0.77% from its 52-week high.
Profound Medical Corp. (PROF) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Profound Medical Corp. (PROF) is a “Buy”. 8 analysts offering their recommendations for the stock, where 1 rate it as a Hold and 0 think it is a “Overweight”. 7 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Profound Medical Corp. is expected to release its quarterly report on 05/13/2021..
Profound Medical Corp. (PROF) Top Institutional Holders
63 institutions hold shares in Profound Medical Corp. (PROF), with 377.6k shares held by insiders accounting for 1.92% while institutional investors hold 48.02% of the company’s shares. The shares outstanding are 19.63M, and float is at 18.07M with Short Float at 1.88%. Institutions hold 47.09% of the Float.
The top institutional shareholder in the company is FIL LTD with over 1.13 million shares valued at $19.85 million. The investor’s holdings represent 5.57% of the PROF Shares outstanding. As of Sep 29, 2020, the second largest holder is Redmile Group, LLC with 0.82 million shares valued at $14.55 million to account for 4.08% of the shares outstanding. The other top investors are Pura Vida Investments, LLC which holds 0.78 million shares representing 3.86% and valued at over $13.77 million, while Gagnon Securities, LLC holds 3.86% of the shares totaling 0.78 million with a market value of $13.75 million.